# clm_ADE56CD2A2B3

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: total_assets  
value: 1,350,159,000 United States dollar  
valid_from: 2012-03-31  
valid_to: 2012-06-30  
published: 2012-04-26  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_A3017E7DE44C  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals total assets: 1,350,159,000 United States dollar", as of 2012-03-31 (until 2012-06-30). Claim clm_ADE56CD2A2B3, https://asof.is/claim/clm_ADE56CD2A2B3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000120677412001689/0001206774-12-001689-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:Assets in 10-Q Q1 FY2012, filed 2012-04-26  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000120677412001689/0001206774-12-001689-index.htm (primary, SEC EDGAR 10-Q Q1 FY2012, published 2012-04-26)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 1,323,583,000 United States dollar | valid 2011-12-31 to 2012-03-31 | conf 0.95 | superseded | superseded_by [clm_ADE56CD2A2B3](/claim/clm_ADE56CD2A2B3.md) | [clm_545A6A3B5E05](/claim/clm_545A6A3B5E05.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.